Energy stocks rise amid market gains but underperform S&P 500
Smith & Nephew shares surge on strong first-half 2025 results, driven by demand for medical devices and a $500 million share buyback.
Lowering the recommended age for colorectal cancer screening has led to a significant rise in screening rates among US adults aged 45 to 49, with early-stage diagnoses nearly doubling.
Energy stocks rise amid market gains but underperform S&P 500
Smith & Nephew shares surge on strong first-half 2025 results, driven by demand for medical devices and a $500 million share buyback.
Lowering the recommended age for colorectal cancer screening has led to a significant rise in screening rates among US adults aged 45 to 49, with early-stage diagnoses nearly doubling.